Pfizer asks U.S. regulators to OK emergency use of COVID vaccine
Published
With the coronavirus surging around the U.S. and the world, the pressure is on for regulators to make a speedy decision.
Full ArticlePublished
With the coronavirus surging around the U.S. and the world, the pressure is on for regulators to make a speedy decision.
Full ArticleWatch VideoThe need for a COVID vaccine is greater than ever before as cases surge and hospitals are overwhelmed in much of the..
Moderna is just behind Pfizer and its German partner BioNTech in seeking to begin vaccinations in the US in December.